Accessibility Menu
 
Nexalin Technology logo

Nexalin Technology

(NASDAQ) NXL

Current Price$0.37
Market Cap$7.20M
Since IPO (2022)-84%
5 YearN/A
1 Year-79%
1 Month-12%

Nexalin Technology Financials at a Glance

Market Cap

$7.20M

Revenue (TTM)

$301.65K

Net Income (TTM)

$8.22M

EPS (TTM)

$-0.51

P/E Ratio

-0.69

Dividend

$0.00

Beta (Volatility)

1.32 (Average)

Price

$0.37

Volume

72,223

Open

$0.36

Previous Close

$0.37

Daily Range

$0.33 - $0.40

52-Week Range

$0.33 - $2.31

NXL News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Nexalin Technology

Industry

Healthcare Equipment and Supplies

Employees

8

CEO

Mark White

Headquarters

Houston, TX 77056, US

NXL Financials

Key Financial Metrics (TTM)

Gross Margin

-3%

Operating Margin

-28%

Net Income Margin

-27%

Return on Equity

-222%

Return on Capital

-2%

Return on Assets

-2%

Earnings Yield

-1.45%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$7.20M

Shares Outstanding

20.58M

Volume

72.22K

Short Interest

0.00%

Avg. Volume

299.81K

Financials (TTM)

Gross Profit

$1.64M

Operating Income

$8.39M

EBITDA

$8.39M

Operating Cash Flow

$4.96M

Capital Expenditure

$0.00

Free Cash Flow

$4.96M

Cash & ST Invst.

$3.72M

Total Debt

$0.00

Nexalin Technology Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$171.90K

+532.5%

Gross Profit

$574.57K

-3019.1%

Gross Margin

-3.34%

N/A

Market Cap

$7.20M

N/A

Market Cap/Employee

$1.20M

N/A

Employees

6

N/A

Net Income

$2.38M

+16.1%

EBITDA

$2.41M

+16.2%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$3.72M

+7.0%

Accounts Receivable

$81.57K

+525.4%

Inventory

$131.47K

-24.7%

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-1.77%

N/A

Return on Invested Capital

-2.24%

N/A

Free Cash Flow

$1.15M

+0.2%

Operating Cash Flow

$1.15M

-1.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CLGNCollPlant Biotechnologies Ltd.
$0.38+13.27%
RBOTVicarious Surgical Inc.
$0.75-3.85%
IINNInspira Technologies Oxy B.H.N. Ltd.
$0.41-4.44%
MODDModular Medical, Inc.
$5.02-1.57%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.45+0.02%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$6.78-0.02%
TQQQProShares Trust - ProShares UltraPro Qqq
$48.96+0.02%
CRWVCoreWeave
$92.00+0.03%

Questions About NXL

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.